Literature DB >> 11710860

Effect of blended carbon dioxide and erbium:YAG laser energy on preauricular and ear lobule keloid fibroblast secretion of growth factors: a serum-free study.

E T Cheng1, K C Nowak, R J Koch.   

Abstract

BACKGROUND: A serum-free in vitro model was used to determine the effect of combined carbon dioxide (CO2) and erbium (Er):YAG laser (Derma K; ESC/Sharplan Medical Systems, Yokneam, Israel) irradiation on keloid-producing fibroblasts (KFs) from 2 distinct facial sites. Transforming growth factor beta1 (TGF-beta1) and basic fibroblast growth factor (bFGF) play an integral part in wound healing and were assayed using this model. It has always been a clinical impression that fibroblasts from different regions of the face behave differently. This is exemplified by patients prone to lobule keloid formation after ear piercing, who heal normally after a facial incision.
DESIGN: Laboratory-based wound healing.
METHODS: Human KF cell lines were established from operative specimens using standard explant techniques. At 48 hours after seeding, 20% of each well was exposed to 1.7 J/pulse of Er:YAG laser energy and CO2 delivered at 3 or 5 W and at a duty cycle of 25%, 50%, or 100%. Using a quantitative enzyme-linked immunosorbent assay, TGF-beta1 and bFGF were assayed from collected supernatants.
RESULTS: Laser-treated ear lobule KFs demonstrated decreased TGF-beta1 production when compared with preauricular KFs. Statistical significance (P<.005) was seen in the 3-W CO2 25% duty cycle; a trend was seen in the 3-W CO2 50% duty cycle (P<.08). Preauricular KFs secreted increased bFGF when compared with lobule KFs. Significance was seen in the 3-W CO2 25% and 50% duty cycles (P<.05). Laser-treated preauricular KFs had increased bFGF secretion when compared with non-laser-treated preauricular KFs in the 3-W CO2 25%, 50%, and 100% duty cycles.
CONCLUSIONS: Combined CO2 and Er:YAG laser treatment decreases the production of TGF-beta1 in preauricular and ear lobule KFs. This laser may have clinical promise in the treatment of keloids. Finally, the different growth factor profiles obtained suggest that KFs from the ear lobule and preauricular regions are different.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11710860     DOI: 10.1001/archfaci.3.4.252

Source DB:  PubMed          Journal:  Arch Facial Plast Surg        ISSN: 1521-2491


  4 in total

Review 1.  Treatment of keloid scars using light-, laser- and energy-based devices: a contemporary review of the literature.

Authors:  E Forbat; F R Ali; F Al-Niaimi
Journal:  Lasers Med Sci       Date:  2017-10-18       Impact factor: 3.161

Review 2.  The Use of Chemotherapeutics for the Treatment of Keloid Scars.

Authors:  Christopher David Jones; Luke Guiot; Mike Samy; Mark Gorman; Hamid Tehrani
Journal:  Dermatol Reports       Date:  2015-05-21

3.  A new CO2 laser technique for the treatment of pediatric hypertrophic burn scars: An observational study.

Authors:  Tomasz Żądkowski; Paweł Nachulewicz; Maciej Mazgaj; Magdalena Woźniak; Czesław Cielecki; Andrzej Paweł Wieczorek; Iwona Beń-Skowronek
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

4.  Fractional Carbon Dioxide, Long Pulse Nd:YAG and Pulsed Dye Laser in the Management of Keloids.

Authors:  Ashwini Annabathula; C Shanmuga Sekar; C R Srinivas
Journal:  J Cutan Aesthet Surg       Date:  2017 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.